AstraZeneca, headquartered in Cambridge, could pay up to $1 billion on a cash and debt-free basis for Belgian company ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

Researchers have discovered that cancer cells suppress 'poison exons' -- genetic elements that act as an off switch for protein production -- in a key gene called TRA2 , promoting tumor growth. By ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

When it comes to lung cancer, the idea that diet could play a role is rarely discussed. Researchers from the University of ...

A 68-year-old man with prostate cancer develops penile metastases, a rare but serious complication, reinforcing the need for ...

Nicotinamide riboside (NR), a form of vitamin B3, has been widely promoted for its potential health benefits, including ...

Researchers in China have used the body’s own immune system to kill cancerous cells in a pioneering new therapy.

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.